• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高葡萄糖通过蛋白酶激活受体-4增强人血管平滑肌细胞中的凝血酶反应。

High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells.

机构信息

Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.

出版信息

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):624-33. doi: 10.1161/ATVBAHA.110.219105. Epub 2010 Dec 16.

DOI:10.1161/ATVBAHA.110.219105
PMID:21164077
Abstract

OBJECTIVE

Diabetes is associated with vascular remodeling and increased thrombin generation. Thrombin promotes vascular smooth muscle cell (SMC) mitogenesis and migration via protease-activated receptors (PAR)-1, PAR-3, and PAR-4. We investigated the effect of high glucose on expression and function of vascular thrombin receptors.

METHODS AND RESULTS

In human vascular SMCs, high glucose (25 versus 5.5 mmol/L) induced a rapid and sustained increase in PAR-4 mRNA, protein, and cell surface expression. PAR-1 and PAR-3 expression were not changed. High glucose pretreatment (48 hours) enhanced thrombin or PAR-4-activating peptide but not PAR-1-activating peptide evoked intracellular calcium mobilization, migration, and tumor necrosis factor α gene expression. This enhancement of thrombin-stimulated migration and gene expression by high glucose was abolished by endogenous PAR-4 knockdown. PAR-4 regulation was prevented by inhibition of protein kinase (PK)C-β and -δ isoforms or nuclear factor (NF)κB. Nuclear translocation of NFκB in high glucose-stimulated SMCs led to PKC-dependent NFκB binding to the PAR-4 promoter in a chromatin immunoprecipitation assay. Furthermore, in situ hybridization and immunohistochemistry confirmed high abundance of PAR-4 in human diabetic vessels as compared with nondiabetic vessels.

CONCLUSIONS

High glucose enhances SMC responsiveness to thrombin through transcriptional upregulation of PAR-4, mediated via PKC-β, -δ, and NFκB. This may play an important role in the vascular complications of diabetes.

摘要

目的

糖尿病与血管重塑和凝血酶生成增加有关。凝血酶通过蛋白酶激活受体(PAR)-1、PAR-3 和 PAR-4 促进血管平滑肌细胞(SMC)有丝分裂和迁移。我们研究了高血糖对血管凝血酶受体表达和功能的影响。

方法和结果

在人血管 SMC 中,高葡萄糖(25 与 5.5mmol/L)诱导 PAR-4mRNA、蛋白和细胞表面表达迅速而持续增加。PAR-1 和 PAR-3 的表达没有改变。高葡萄糖预处理(48 小时)增强了凝血酶或 PAR-4 激活肽,但不增强 PAR-1 激活肽引起的细胞内钙动员、迁移和肿瘤坏死因子α基因表达。高葡萄糖增强凝血酶刺激的迁移和基因表达的这种增强被内源性 PAR-4 敲低所消除。PKC-β和-δ同工型或核因子(NF)κB 的抑制阻止了 PAR-4 的调节。在高葡萄糖刺激的 SMC 中,NFκB 的核易位导致 PKC 依赖性 NFκB 与 PAR-4 启动子在染色质免疫沉淀测定中的结合。此外,原位杂交和免疫组织化学证实,与非糖尿病血管相比,PAR-4 在人糖尿病血管中的丰度很高。

结论

高葡萄糖通过 PAR-4 的转录上调增强 SMC 对凝血酶的反应性,介导途径为 PKC-β、-δ 和 NFκB。这可能在糖尿病的血管并发症中起重要作用。

相似文献

1
High glucose enhances thrombin responses via protease-activated receptor-4 in human vascular smooth muscle cells.高葡萄糖通过蛋白酶激活受体-4增强人血管平滑肌细胞中的凝血酶反应。
Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):624-33. doi: 10.1161/ATVBAHA.110.219105. Epub 2010 Dec 16.
2
Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription.Rac-1通过上调纤溶酶原激活物抑制剂-1促进肺动脉平滑肌细胞增殖:核因子κB依赖的缺氧诱导因子-1α转录的作用
Thromb Haemost. 2008 Dec;100(6):1021-8.
3
Transcriptional inhibition of protease-activated receptor-1 expression by prostacyclin in human vascular smooth muscle cells.前列环素对人血管平滑肌细胞中蛋白酶激活受体-1表达的转录抑制作用。
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):534-40. doi: 10.1161/ATVBAHA.107.159483. Epub 2007 Dec 27.
4
Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells.人类血管平滑肌细胞中功能性活性蛋白酶激活受体-4(PAR-4)的证据。
Br J Pharmacol. 2001 Apr;132(7):1441-6. doi: 10.1038/sj.bjp.0703947.
5
Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT.血管舒张性前列腺素通过核因子活化T细胞经蛋白酶激活受体-1的调控
Cardiovasc Res. 2009 Sep 1;83(4):778-84. doi: 10.1093/cvr/cvp163. Epub 2009 May 21.
6
Thrombin receptors in vascular smooth muscle cells - function and regulation by vasodilatory prostaglandins.血管平滑肌细胞中的凝血酶受体——血管扩张性前列腺素的功能和调节。
Thromb Haemost. 2010 May;103(5):884-90. doi: 10.1160/TH09-09-0627. Epub 2010 Feb 8.
7
Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.凝血酶介导的肝癌细胞迁移:通过蛋白酶激活受体1和4的协同作用
J Cell Physiol. 2007 Jun;211(3):699-707. doi: 10.1002/jcp.21027.
8
Thrombin enhanced migration and MMPs expression of human chondrosarcoma cells involves PAR receptor signaling pathway.凝血酶通过 PAR 受体信号通路增强人软骨肉瘤细胞的迁移和 MMPs 的表达。
J Cell Physiol. 2010 Jun;223(3):737-45. doi: 10.1002/jcp.22083.
9
Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells.蛋白酶激活受体-2(PAR-2)介导冠状动脉平滑肌细胞有丝分裂的证据。
Br J Pharmacol. 1999 Apr;126(8):1735-40. doi: 10.1038/sj.bjp.0702509.
10
Thrombin induces EGF receptor expression and cell proliferation via a PKC(delta)/c-Src-dependent pathway in vascular smooth muscle cells.凝血酶通过蛋白激酶C(δ)/c-Src依赖途径诱导血管平滑肌细胞中表皮生长因子受体的表达和细胞增殖。
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1594-601. doi: 10.1161/ATVBAHA.109.185801. Epub 2009 Jul 23.

引用本文的文献

1
Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes.凝血酶受体PAR4在心房心肌细胞中交叉激活酪氨酸激酶c-met。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2783-2796. doi: 10.1007/s00210-024-03436-6. Epub 2024 Sep 16.
2
The thrombin receptor PAR4 supports visceral adipose tissue inflammation.凝血酶受体 PAR4 支持内脏脂肪组织炎症。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):7187-7200. doi: 10.1007/s00210-024-03097-5. Epub 2024 Apr 23.
3
PKCδ regulates the vascular biology in diabetic atherosclerosis.
蛋白激酶 C 亚型 δ 调控糖尿病动脉粥样硬化中的血管生物学。
Cell Commun Signal. 2023 Nov 16;21(1):330. doi: 10.1186/s12964-023-01361-4.
4
Changes in Protease-Activated Receptor and Trypsin-1 Expression Are Involved in the Therapeutic Effect of Mg Supplementation in Type 2 Diabetes-Induced Gastric Injury in Male Adult Rats.蛋白酶激活受体和胰蛋白酶-1表达的变化与镁补充对成年雄性大鼠2型糖尿病诱导的胃损伤的治疗作用有关。
Adv Pharmacol Pharm Sci. 2023 May 16;2023:5703718. doi: 10.1155/2023/5703718. eCollection 2023.
5
Species Differences in Platelet Protease-Activated Receptors.血小板蛋白酶激活受体的种属差异。
Int J Mol Sci. 2023 May 5;24(9):8298. doi: 10.3390/ijms24098298.
6
Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand.中性粒细胞组织蛋白酶 G 对蛋白酶激活受体 4 的蛋白水解作用产生了一种新型的、有功能的连接配体。
Blood Adv. 2022 Apr 12;6(7):2303-2308. doi: 10.1182/bloodadvances.2021006133.
7
YTHDC2-Mediated circYTHDC2 N6-Methyladenosine Modification Promotes Vascular Smooth Muscle Cells Dysfunction Through Inhibiting Ten-Eleven Translocation 2.YTHDC2介导的环状YTHDC2 N6-甲基腺苷修饰通过抑制10-11易位蛋白2促进血管平滑肌细胞功能障碍。
Front Cardiovasc Med. 2021 Oct 1;8:686293. doi: 10.3389/fcvm.2021.686293. eCollection 2021.
8
PAR-4/Ca-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes.PAR-4/Ca-钙蛋白酶通路激活可刺激高血糖 2 型糖尿病中的血小板衍生的微颗粒。
Cardiovasc Diabetol. 2021 Apr 3;20(1):77. doi: 10.1186/s12933-021-01267-w.
9
Predictive Value of Fasting Blood Glucose for Microvascular Obstruction in Nondiabetic Patients with ST-Segment Elevation Myocardial Infarction after Primary Percutaneous Coronary Intervention.非糖尿病ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后空腹血糖对微血管阻塞的预测价值
Cardiol Res Pract. 2020 Sep 26;2020:8429218. doi: 10.1155/2020/8429218. eCollection 2020.
10
Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.凝血酶受体 PAR4 驱动心脏中的经典 NLRP3 炎性小体信号转导。
Basic Res Cardiol. 2020 Jan 7;115(2):10. doi: 10.1007/s00395-019-0771-9.